"Tablets, Enteric-Coated" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tablets coated with material that delays release of the medication until after they leave the stomach. (Dorland, 28th ed)
| Descriptor ID |
D013608
|
| MeSH Number(s) |
D26.255.210.860 D26.255.830.860
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tablets, Enteric-Coated".
Below are MeSH descriptors whose meaning is more specific than "Tablets, Enteric-Coated".
This graph shows the total number of publications written about "Tablets, Enteric-Coated" by people in this website by year, and whether "Tablets, Enteric-Coated" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2006 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2014 | 1 | 1 | 2 |
| 2016 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Tablets, Enteric-Coated" by people in Profiles.
-
D'Amore T, Cozzarelli NF, Sutton R, Lonner JH, Fillingham YA. Low-Dose Enteric-Coated and Chewable Aspirin Are Not Equally Effective in Preventing Venous Thromboembolism in Total Knee and Hip Arthroplasty. J Arthroplasty. 2024 09; 39(9 Suppl 2):S129-S133.
-
Goldstein JL, Scheiman JM, Fort JG, Whellan DJ. Aspirin Use in Secondary Cardiovascular Protection and the Development of Aspirin-Associated Erosions and Ulcers. J Cardiovasc Pharmacol. 2016 Aug; 68(2):121-6.
-
Langone A, Shihab F, Pankewycz O, Doria C, Wiland A, McCague K, Chan L. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation. Clin Transplant. 2014 Sep; 28(9):961-7.
-
Whellan DJ, Goldstein JL, Cryer BL, Eisen GM, Lanas A, Miller AB, Scheiman JM, Fort JG, Zhang Y, O'Connor C. PA32540 (a coordinated-delivery tablet of enteric-coated aspirin 325 mg and immediate-release omeprazole 40 mg) versus enteric-coated aspirin 325 mg alone in subjects at risk for aspirin-associated gastric ulcers: results of two 6-month, phase 3 studies. Am Heart J. 2014 Oct; 168(4):495-502.e4.
-
Doria C, Ramirez CB, Frank AM, Vaccino S, Fraser N, Marino IR. Use of enteric-coated mycophenolate sodium in liver transplant patients with intestinal intolerance caused by mycophenolate mofetil. Clin Transplant. 2009 Nov-Dec; 23(6):882-6.
-
Kobashigawa JA, Renlund DG, Gerosa G, Almenar L, Eisen HJ, Keogh AM, Lehmkuhl HB, Livi U, Ross H, Segovia J, Yonan N. Similar efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS, myfortic) compared with mycophenolate mofetil (MMF) in de novo heart transplant recipients: results of a 12-month, single-blind, randomized, parallel-group, multicenter study. J Heart Lung Transplant. 2006 Aug; 25(8):935-41.